This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Biomerieux, Inc.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ouillins, FR (2016)
- Oullins, FR (2014 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Innovations of Lionel Levet in Lyme Borreliosis Diagnosis
Introduction
Lionel Levet is a notable inventor based in Oullins, France. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of Lyme borreliosis. With a total of 4 patents to his name, his work has the potential to impact the healthcare industry positively.
Latest Patents
Lionel Levet's latest patents focus on proteins used for the diagnosis of Lyme borreliosis. These include chimera proteins that consist of at least one sequence of a DbpA protein and at least one sequence of an OspC protein from specific species. Additionally, he has developed a method and a kit for the in vitro diagnosis of Lyme borreliosis utilizing these proteins. This innovative approach aims to enhance the accuracy and efficiency of Lyme disease diagnosis.
Career Highlights
Lionel Levet is currently associated with bioMérieux, Inc., a company renowned for its expertise in in vitro diagnostics. His work at bioMérieux has allowed him to collaborate with other experts in the field, further advancing the development of diagnostic tools.
Collaborations
Some of Lionel Levet's coworkers include Odile Mejan-Letourneur, who has also contributed to the research and development efforts in the field of diagnostics. Their collaborative work has been instrumental in pushing the boundaries of current medical technologies.
Conclusion
Lionel Levet's innovative contributions to the diagnosis of Lyme borreliosis exemplify the importance of research and development in the medical field. His patents and ongoing work at bioMérieux, Inc. highlight the potential for advancements in healthcare diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
